Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001357211-08-000001
Filing Date
2008-01-03
Accepted
2008-01-03 18:42:43
Documents
1
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3787
  Complete submission text file 0001357211-08-000001.txt   5645
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Issuer) CIK: 0001159019 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8664 PARKHOUSE DRIVE MT BRYDGES A6 N0L 1W0
Business Address 519-264-1164
Clarke Janice Marie (Reporting) CIK: 0001357211 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31198 | Film No.: 08508638